Vor Bio grants stock options for 32,550 shares, RSUs for 6,900 shares to new hires under inducement plan
Reuters2026/08/03 20:39- Vor Bio granted inducement equity awards on Aug. 1, 2026 to five new hires under its 2023 Inducement Plan.
- Awards include stock options for 32,550 shares, priced at USD 21.15, matching the grant-date close; options run 10 years.
- RSUs cover 6,900 shares; both options and RSUs vest over four years, with 25% after 12 months.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.
2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
